CNR Institutional Research Information System

PISANO, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.985
NA - Nord America 831
EU - Europa 523
SA - Sud America 346
AF - Africa 31
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.721
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 844
US - Stati Uniti d'America 795
CN - Cina 463
BR - Brasile 294
HK - Hong Kong 242
IT - Italia 240
VN - Vietnam 144
KR - Corea 112
NL - Olanda 87
DE - Germania 47
IN - India 38
GB - Regno Unito 30
FI - Finlandia 28
AT - Austria 25
AR - Argentina 24
JP - Giappone 22
IL - Israele 21
BD - Bangladesh 18
MX - Messico 16
ZA - Sudafrica 16
ID - Indonesia 14
CA - Canada 13
PL - Polonia 12
TR - Turchia 11
IQ - Iraq 9
FR - Francia 8
EC - Ecuador 7
IE - Irlanda 7
SA - Arabia Saudita 7
UA - Ucraina 7
UZ - Uzbekistan 7
SE - Svezia 6
PK - Pakistan 5
PY - Paraguay 5
CO - Colombia 4
CZ - Repubblica Ceca 4
ES - Italia 4
KE - Kenya 4
KZ - Kazakistan 4
MA - Marocco 4
RU - Federazione Russa 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
MY - Malesia 3
UY - Uruguay 3
VE - Venezuela 3
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
JM - Giamaica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MZ - Mozambico 1
PH - Filippine 1
PT - Portogallo 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.721
Salva come PNG Salva come JPEG
Città #
Singapore 517
Santa Clara 300
Hefei 247
Hong Kong 241
Seoul 108
Beijing 87
Ashburn 69
San Jose 55
Ho Chi Minh City 54
Dallas 49
Hanoi 36
Los Angeles 33
São Paulo 33
Cavallino 28
Boardman 23
Guangzhou 23
San Gregorio di Catania 21
Milan 20
Vienna 19
Cagliari 17
Frankfurt am Main 16
Helsinki 15
Minamishinagawa 15
Amsterdam 14
Buffalo 14
Bari 12
Bengaluru 12
Sala Baganza 12
Düsseldorf 11
New York 11
Rio de Janeiro 11
Turku 11
Assemini 10
Naples 10
Warsaw 10
Johannesburg 8
Munich 8
Denver 7
Dublin 7
Jakarta 7
Mexico City 6
Phoenix 6
Tashkent 6
Tokyo 6
Brasília 5
Genoa 5
Hortolândia 5
Hải Dương 5
Istanbul 5
London 5
Porto Alegre 5
Rome 5
Salvador 5
San Francisco 5
Sassari 5
Baghdad 4
Belo Horizonte 4
Boston 4
Brooklyn 4
Charlotte 4
Curitiba 4
Guayaquil 4
Haiphong 4
Lauterbourg 4
Manchester 4
Montreal 4
Nairobi 4
Perugia 4
Stockholm 4
Sumaré 4
Ankara 3
Asunción 3
Betim 3
Biên Hòa 3
Buenos Aires 3
Casablanca 3
Chennai 3
Chicago 3
Da Nang 3
Dhaka 3
Falkenstein 3
Feira de Santana 3
Florence 3
Guarulhos 3
Houston 3
Lucknow 3
Macomer 3
Orem 3
Phủ Lý 3
Quận Một 3
Riyadh 3
Rovato 3
Tel Aviv 3
Afragola 2
Almaty 2
Angra dos Reis 2
Aparecida de Goiânia 2
Araraquara 2
Araruama 2
Arezzo 2
Totale 2.423
Salva come PNG Salva come JPEG
Nome #
Inhibitory Effect of Curcumin-Inspired Derivatives on Tyrosinase Activity and Melanogenesis 93
ANTIPROLIFERATIVE ACTIVITY OF VANADIUM COMPOUNDS: EFFECTS ON THE MAJOR MALIGNANT MELANOMA MOLECULAR PATHWAYS 79
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population 76
Michael Acceptor Bearing A Hydroxylated Biphenyl Structure As Molecular Core For New Compounds Against Malignant Melanoma Cells 72
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 70
Antioxidant, Antimicrobial, and Other Biological Properties of Pompia Juice 67
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia 65
Attività anti-proliferativa e pro-apoptotica di bifenili derivati dall eugenolo e dall isoeugenolo su cellule tumorali di melanoma maligno. 64
Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report 64
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 64
Synthesis of Hydroxylated Biphenyls Derivatives Bearing an Alpha, Beta-Unsaturated Ketone as Lead Structure for the Development of New Drug Candidates Against Malignant Melanoma 62
Il CSCC: aspetti distintivi della patologia 61
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 61
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 59
Molecular Basis of open-angle glaucoma in Italy 58
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 58
Anticancer activity of two novel hydroxylated biphenyl compounds toward malignant melanoma cells 58
Germline and somatic NGS-based analysis on BRCA-related tumors 58
In vitro and in vivo evaluation of the antitumour activity for a new curcumin-related compound in melanoma and neuroblastoma cells 51
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 50
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 50
Molecular landscape profile of melanoma 49
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 49
Analoghi strutturali della curcumina come potenziali agenti antitumorali contro il melanoma maligno. 48
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 48
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 45
Liquid biopsy in clinical oncology 45
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 44
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 43
Antitumoral effects of Vanadium compounds in malignant melanoma cell lines 43
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 43
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 40
Preparation of new hydroxylated natural-like biphenyls and their antitumoral activity. 40
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 40
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 40
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma 40
Functionalization of Hydroxylated Phenols and Biphenols Bearing an a,b-Unsaturated Keton as Lead Compound 40
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 40
"Proprietà Funzionali e Possibile Valorizzazione delle Foglie di Vitigni Endemici" 39
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 38
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 37
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 36
Proteomic analysis in melanoma cell lines with different genotypes 34
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 34
Polimorfismi del sistema renina-angiotensina in una popolazione del Nord Sardegna: associazione fra angiotensinogeno ed ipertensione arteriosa essenziale ad insorgenza precoce. 34
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 34
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 33
Antiproliferative activity of eugenol and curcumin related biphenyls on malignant melanoma cell lines 31
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 31
Caratterizzazione dei meccanismi d'azione coinvolti nell'attività antitumorale di composti del vanadio su cellule di melanoma maligno 31
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 30
DISSECTING MOLECULAR PATHWAYS INVOLVED IN THE ANTIPROLIFERATIVE EFFECTS OF VANADIUM COMPOUNDS IN A375 MALIGNANT MELANOMA CELL LINE. 28
Identification of a founder BRCA2 mutation in Sardinia 28
"Genomic instability of the human chromosome 10q25-q26 in patients with endometrial cancer". In New technologies for gynecologic and obstetric investigation. 4th Congress of the European society for gynecologic and obstetric investigation (1999) 28
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 27
A refined physical and EST map spanning 7.4 Mb of 10q24, a region involved in neurological disorders 27
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 27
BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling 26
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 26
L'istituto di Chimica Biomolecolare a Sassari, Parte seconda 25
Mechanism of pathogenicity in Salmonella abortusovis 25
In vitro activity of the alfavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells. 24
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 24
A novel candidate gene in human endometrial cancer at chromosome 10q26 24
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 23
Molecular changes induced by the curcumin biphenyl analogue D6 in melanoma cells 23
Search for therapeutic response molecular markers in malignant melanoma through NGS: on the way to an anti-BRAF combination therapy. 23
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 23
Molecular basis of open-angle glaucoma in Italy 22
Caratterizzazione dei Meccanismi Molecolari Alla Base dell Attivita Antitumorale dell Analogo Struttuale della Curcumina D6. 22
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 22
Cloning, expression, and function of TFC5, the gene encoding the B'' component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB 21
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 21
Microsatellite Analysis at 10q25-q26 in Sardinian Patients with Sporadic Endometrial Carcinoma:Identification of Specific Patterns of Genetic Alteration 21
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. 20
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 20
"Transcription by RNA polimerase III" In Transcription: Mechanism and Regulation 20
2,2-dihydroxy-3,3-dimethoxy-5,5-dimethyl-6,6-dibromo-1,1-biphenyl: preparation, resolution, structure and biological activity. 20
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 20
The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB 20
4-Substituted-2-Methoxyphenol: Suitable Building Block to Prepare New Bioactive Natural-like Hydroxylated Biphenyls 20
Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6 19
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 19
Studio Biologico Cellulare e Molecolare di Nuovi Composti Bioattivi nel Melanoma Maligno 19
Natural derived hydroxylated byphenyl compounds as potential anti-melanoma agents. 19
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland 19
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 19
ASSESSMENT OF THE IN VITRO ACTIVITY OF RGDECHI-HCIT, alpha V beta3 INTEGRIN ANTAGONIST, ON MALIGNANT MELANOMA CELLS 18
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 18
Attivita Antiproliferativa e Proapoptotica di Bifenili relazionabili alla struttura della curcumina su Cellule di Melanoma Maligno 18
Molecular changes induced by the curcumin analogue D6 in human melanoma cells 18
Profilo dell espressione genica in cellule di melanoma maligno trattate con un analogo strutturale della curcumina 18
Preparazione, Risoluzione, Struttura ed Attività Citotossica di un Equivalente Bromurato del Deidrodicreosolo 18
Molecular Changes Induced by the Hydroxylated Byphenyl Analogue of Curcumin D6 in Melanoma Cells 18
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 18
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 18
Preparation of new hydroxylated Natural-like Biphenyls and their Antitumoral Activity Against Malignant Melanoma 17
Antiproliferative and pro-apoptotic activity of eugenol related biphenyls on malignant melanoma tumour cell lines 17
Sviluppo di Bifenili Idrossilati analoghi della curcumina come agenti antitumorali contro il MElanoma maligno - BICOME 17
La chimica biomolecolare entra nelle scuole: Alla ricerca di nuove terapie contro il melanoma 17
Totale 3.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.630
article - articoli 8.053
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 532
Totale 21.215
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202479 0 0 0 0 0 0 0 0 4 2 51 22
2024/20251.849 21 5 105 80 321 104 58 114 79 110 467 385
2025/20261.909 190 272 282 389 547 153 76 0 0 0 0 0
Totale 3.837